United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Phio Pharmaceuticals Corp.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -69.95% | -55.09% | -122.49% | 543.98% | 84.51% | 45.84% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -63.9% | -50.78% | -103.04% | - | 97.14% | 49.32% |
| Total Assets | $21,487.00K | $12,785.17K | $4,090.62K | - | - | - |
| Sector average | $3,280,499.23K | $3,298,345.31K | $3,676,894.01K | |||
| Net Income | -$8,698.00K | -$8,701.83K | -$8,694.55K | -$8,699.80K | -$8,705.98K | -$8,716.50K |
| $4,262,561.28K |
| $4,994,412.92K |
| $5,761,557.24K |